Acorda Therapeutics, Inc.
Q1 2023 13F Holders
Symbol
ACOR
CUSIP
00484M601
Type
Equity
Class
COM NEW
Num filings
32
Total reported value, excl. options
$3.71 M
Compare 2023 Q1 to
2022 Q4
2022 Q3
2022 Q2
2022 Q1
2021 Q4
2021 Q3
2021 Q2
2021 Q1
2020 Q4
2019 Q3
2019 Q2
2019 Q1
2018 Q4
2018 Q3
2018 Q2
2018 Q1
2017 Q4
2017 Q3
2017 Q2
2017 Q1
2016 Q4
2016 Q3
Manager
Report Date
Value ($000)
Shares
Option Type